# CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

> **NCT05726526** · NA · RECRUITING · sponsor: **University of Manitoba** · enrollment: 340 (estimated)

## Conditions studied

- Chronic Kidney Disease Stage 5
- End Stage Renal Disease

## Interventions

- **DEVICE:** VIEWER virtual care platform

## Key facts

- **NCT ID:** NCT05726526
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-30
- **Primary completion:** 2027-03-30
- **Final completion:** 2028-03-30
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05726526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05726526, "CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05726526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*